Tenon Medical, Inc. SEC filings TNONW
Tenon Medical, Inc. has 300 filings in SEC EDGAR's recent list, going back to Oct 16, 2012. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Jun 23, 2026 | Jul 23, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 12, 2026 | Jun 12, 2026 |
| DEF 14A | Proxy statement | Jun 17, 2025 | Jul 23, 2025 |
| PRE 14A | Preliminary proxy statement | Jun 5, 2025 | Jun 4, 2025 |
| DEF 14A | Proxy statement | Jun 13, 2024 | Jul 23, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 3, 2024 | Jul 23, 2024 |
| DEF 14A | Proxy statement | Nov 22, 2023 | Dec 21, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 8, 2023 | Nov 8, 2023 |
| DEF 14A | Proxy statement | Aug 4, 2023 | Sep 13, 2023 |
| PRE 14A | Preliminary proxy statement | Jul 25, 2023 | Sep 13, 2023 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TNON (Nasdaq), TNONW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Gatos, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1560293
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.